Other than the original quoted article from Bioworld and Recce announcing that it is targeting the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) global initiative, which is offering a $1 billion reward for each new antibiotic approved, as well as increased R&D funding, I found the following articles and websites that mention these sort of rewards, there is also the Billions of potential revenue for any company that gets a new superbug antibiotic approved.
https://www.washingtonpost.com/opin...ory.html?noredirect=on&utm_term=.d5077c74e22e
http://www.ip-watch.org/2018/02/15/...d-2018-seeks-partners-antibacterial-research/
http://www.cidrap.umn.edu/news-perspective/2018/01/1-billion-reward-proposed-new-antibiotics
https://www.nature.com/articles/ja2017124
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746591/
- Forums
- ASX - By Stock
- RCE
- Accelerated Approval for RECCE® 327
Accelerated Approval for RECCE® 327, page-27
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
-0.003(0.49%) |
Mkt cap ! $118.1M |
Open | High | Low | Value | Volume |
51.0¢ | 52.5¢ | 51.0¢ | $23.39K | 44.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 35701 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.0¢ | 6981 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 35701 | 0.510 |
1 | 2928 | 0.505 |
2 | 29692 | 0.500 |
1 | 30000 | 0.495 |
1 | 50000 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 6981 | 1 |
0.525 | 27349 | 2 |
0.530 | 10000 | 1 |
0.545 | 1834 | 1 |
0.550 | 54490 | 2 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |